Literature DB >> 26043875

Inactivation of BLU is associated with methylation of Sp1-binding site of BLU promoter in gastric cancer.

Kunting Xiao1, Zhuwen Yu1, Dong-Tao Shi1, Zhe Lei2, Hongbing Chen2, Jian Cao3, Wenyan Tian1, Weichang Chen1, Hong-Tao Zhang2.   

Abstract

BLU is a candidate tumor suppressor gene, which is epigenetically inactivated in many human malignancies. However, the expression and biological functions of BLU in gastric cancer has not yet been reported. In the present study, we identified a functional BLU promoter which was regulated by the transcription activator Sp1. Bisulfite sequencing and qRT-PCR assays indicated that the silence of BLU expression in gastric cancer was significantly associated with DNA hypermethylation of BLU promoter including -39 CpG site located in the Sp1 transcription element. The expression of BLU was notably restored in AGS and SGC7901 cells following the demethylation-treatment with 5'-Aza-2'-deoxycytidine. Moreover, the results from ChIP, EMSA and luciferase reporter gene showed that -39 CpG methylation could prevent Sp1 from binding to the promoter of BLU and decreased transcription activity of the BLU gene by ~70%. In addition, knockdown of BLU significantly promoted cellular proliferation and colony formation in gastric cancer cells. In conclusion, we identified a novel functional BLU promoter and proved that BLU promoter activity was regulated by Sp1. Furthermore, we found that hypermethylated -39 CpG in BLU proximal promoter directly reduced its binding with Sp1, which may be one of the mechanisms accounting for the inactivation of BLU in gastric cancer.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26043875     DOI: 10.3892/ijo.2015.3032

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  4 in total

1.  ZMYND10, an epigenetically regulated tumor suppressor, exerts tumor-suppressive functions via miR145-5p/NEDD9 axis in breast cancer.

Authors:  Yan Wang; Liangying Dan; Qianqian Li; Lili Li; Lan Zhong; Bianfei Shao; Fang Yu; Sanxiu He; Shaorong Tian; Jin He; Qian Xiao; Thomas C Putti; Xiaoqian He; Yixiao Feng; Yong Lin; Tingxiu Xiang
Journal:  Clin Epigenetics       Date:  2019-12-04       Impact factor: 6.551

2.  7-lncRNA Assessment Model for Monitoring and Prognosis of Breast Cancer Patients: Based on Cox Regression and Co-expression Analysis.

Authors:  Huayao Li; Chundi Gao; Lijuan Liu; Jing Zhuang; Jing Yang; Cun Liu; Chao Zhou; Fubin Feng; Changgang Sun
Journal:  Front Oncol       Date:  2019-12-03       Impact factor: 6.244

3.  Coordinated silencing of the Sp1-mediated long noncoding RNA MEG3 by EZH2 and HDAC3 as a prognostic factor in pancreatic ductal adenocarcinoma.

Authors:  Ting Han; Meng Zhuo; Cuncun Yuan; Xiuying Xiao; Jiujie Cui; Guangrong Qin; Liwei Wang; Feng Jiao
Journal:  Cancer Biol Med       Date:  2020-12-15       Impact factor: 4.248

4.  Methylation Status of SP1 Sites within miR-23a-27a-24-2 Promoter Region Influences Laryngeal Cancer Cell Proliferation and Apoptosis.

Authors:  Ye Wang; Zhao-Xiong Zhang; Sheng Chen; Guang-Bin Qiu; Zhen-Ming Xu; Wei-Neng Fu
Journal:  Biomed Res Int       Date:  2016-03-23       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.